ADMA Biologics
ADMA
#3355
Rank
C$6.05 B
Marketcap
C$25.37
Share price
3.28%
Change (1 day)
7.11%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: C$6.05 Billion

As of January 2026 ADMA Biologics has a market cap of C$6.05 Billion. This makes ADMA Biologics the world's 3355th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$6.05 B-3.92%
2025C$6.30 B6.44%
2024C$5.91 B336.95%
2023C$1.35 B16.48%
2022C$1.16 B230.53%
2021C$0.35 B49.68%
2020C$0.23 B-24.14%
2019C$0.30 B105.36%
2018C$0.15 B-17.49%
2017C$0.18 B106.26%
2016C$88.66 M-26.07%
2015C$0.11 B-0.43%
2014C$0.12 B56.12%
2013C$77.15 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of ADMA Biologics was reported to be:

C$5.84 Billion
by Nasdaq info icon info icon
C$5.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
C$1.84 B-69.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$12.65 B 109.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$61.49 M-98.98%๐Ÿ‡บ๐Ÿ‡ธ USA